Skip to main content

waypoint wealth counsel

SEC CIK
0001807909
Latest filing
Aug 4, 2026

ALNY holding history

Alnylam Pharmaceuticals, Inc. in every 13F filed by waypoint wealth counsel, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q3 2025
Holdings of ALNY by waypoint wealth counsel, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−895−100.0%Sold outHolders
Q4 2025895$355.9K0.1%+274+44.1%AddedHolders
Q3 2025621$283.2K0.1%+621NewHolders